Announcement of TTY Biopharm's unaudited
income information in July 2022
Date of events
2022/08/11
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/08/11
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of
$384,643 thousands(expressed in NT dollars; unaudited), a consolidated
operating profit of $91,936 thousands, and a consolidated income
before tax of $101,968 thousands in July 2022; net income attributed to
stockholders of the company was $82,908 thousands; EPS is $0.33.
Year-to-date consolidated net sales was $2,587,275 thousands (in NT
dollars; unaudited), a consolidated operating profit was $636,215
thousands and consolidated income before tax was $740,242 thousands
until July 2022; year-to-date net income attributed to stockholders
of the company was $594,578 thousands; EPS is $2.39.
6.Countermeasures:None.
7.Any other matters that need to be specified:The numbers above are unaudited.
In term of the final net sales and profits, quarterly financial reports
audited by independent accountants will prevail.
Attachments
Original Link
Original Document
Permalink
Disclaimer
TTY Biopharm Co. Ltd. published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 06:00:09 UTC.
TTY Biopharm Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of pharmaceutical preparations. The Company mainly operates through six business segments including Cancer Drug segment, Healthcare segment, Anti-Infective Drug segment, Domestic Cardiovascular and Gastrointestinal Drug segment, Mainland Medical Drug segment and the Other segment. The main products include oncology medicines, anti-infective medicines and health care medicines. Oncology medicines are mainly anti-cancer and auxiliary drugs. Anti-infective medicines are mainly back-line antimicrobial agents and influenza vaccines. Medical and health care medicines are mainly gastrointestinal health care, bone health care, metabolic health care, infection treatment drugs. The Company distributes its products in domestic and overseas markets.
TTY BIOPHARM COMPANY LIMITED 
